UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 833

Sortiert nach

Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv137-iv139

2009

Volltextzugriff (PDF)

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

Annals of oncology, 2012-02, Vol.23 (2), p.508-516

2012

Volltextzugriff (PDF)

Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas

Annals of oncology, 2012-04, Vol.23 (4), p.1067-1073

2012

Volltextzugriff (PDF)

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect

Annals of oncology, 2011-07, Vol.22 (7), p.1682-1690

2011

Volltextzugriff (PDF)

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group

Annals of oncology, 2014-03, Vol.25 (3), p.578-583

2014

Volltextzugriff (PDF)

Sunitinib malate in solitary fibrous tumor (SFT)

Annals of oncology, 2012-12, Vol.23 (12), p.3171-3179

2012

Volltextzugriff (PDF)

Gastrointestinal stromal tumours: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv64-iv67

2009

Volltextzugriff (PDF)

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

European journal of cancer (1990), 2009-07, Vol.45 (11), p.1959-1968

2009

Volltextzugriff (PDF)

Phase II study on lapatinib in advanced EGFR-positive chordoma

Annals of oncology, 2013-07, Vol.24 (7), p.1931-1936

2013

Volltextzugriff (PDF)

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

Annals of oncology, 2012-02, Vol.23 (2), p.501-508

2012

Volltextzugriff (PDF)

Mode of action of trabectedin in myxoid liposarcomas

Oncogene, 2014-10, Vol.33 (44), p.5201-5210

2014

Volltextzugriff (PDF)

The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)

Annals of oncology, 2007-12, Vol.18 (12), p.1923-1925

Casali, P.G.

2007

Volltextzugriff (PDF)

Activity of sunitinib in extraskeletal myxoid chondrosarcoma

European journal of cancer (1990), 2014-06, Vol.50 (9), p.1657-1664

2014

Volltextzugriff (PDF)

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

European journal of cancer (1990), 2014-11, Vol.50 (17), p.3021-3028

2014

Volltextzugriff (PDF)

Response to chemotherapy of solitary fibrous tumour: A retrospective study

European journal of cancer (1990), 2013-07, Vol.49 (10), p.2376-2383

2013

Volltextzugriff (PDF)

Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution

Annals of oncology, 2013-08, Vol.24 (8), p.2181-2189

2013

Volltextzugriff (PDF)

Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?

Annals of oncology, 2010-02, Vol.21 (2), p.403-408

2010

Volltextzugriff (PDF)

Response to imatinib plus sirolimus in advanced chordoma

Annals of oncology, 2009-11, Vol.20 (11), p.1886-1894

2009

Volltextzugriff (PDF)

Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii35-ii38

2008

Volltextzugriff (PDF)

Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study

European journal of cancer (1990), 2019-01, Vol.106, p.225-233

2019

Volltextzugriff (PDF)

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall

Annals of oncology, 2013-03, Vol.24 (3), p.817-823

2013

Volltextzugriff (PDF)

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study

European journal of cancer (1990), 2011-05, Vol.47 (7), p.1006-1012

2011

Volltextzugriff (PDF)

Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1390-1397

2003

Volltextzugriff (PDF)

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics

Clinical cancer research, 2013-09, Vol.19 (18), p.5192-5201

2013

Volltextzugriff (PDF)

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

Annals of oncology, 2009-08, Vol.20 (8), p.1439-1444

2009

Volltextzugriff (PDF)

1 – 25 von 833

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(751)
Mit Volltextzugriff
(745)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group

Sunitinib malate in solitary fibrous tumor (SFT)

Gastrointestinal stromal tumours: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

Phase II study on lapatinib in advanced EGFR-positive chordoma

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

Mode of action of trabectedin in myxoid liposarcomas

The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)

Activity of sunitinib in extraskeletal myxoid chondrosarcoma

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

Response to chemotherapy of solitary fibrous tumour: A retrospective study

Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution

Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?

Response to imatinib plus sirolimus in advanced chordoma

Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study

Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

Suchergebnisse filtern